Status:

UNKNOWN

Retinal Endo Vascular Surgery for Central Retinal Vein Occlusion

Lead Sponsor:

Hadassah Medical Organization

Conditions:

Central Retinal Vein Occlusion

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Patients with Central Retinal Vein Occlusion will undergo vitrectomy, a small needle of about 71 micron will enter a branch retinal vein and TPA will be injected into the obstracted vein.

Detailed Description

Patients with Central Retinal Vein Occlusion less than 6 month duration and reduction of vision to 6/21 will go OCT and FANG examinations. Patient will be operated vitrectomy, and a branch retinal ve...

Eligibility Criteria

Inclusion

  • crvo less than 6 month
  • Visual Acuity less than 6/21
  • No prior eye surgery except cataract.

Exclusion

  • Retinal/iris neovascularization

Key Trial Info

Start Date :

October 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

October 1 2007

Estimated Enrollment :

10 Patients enrolled

Trial Details

Trial ID

NCT00383773

Start Date

October 1 2006

End Date

October 1 2007

Last Update

October 4 2006

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.